Related Experiment Video

Updated: May 17, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Pharmacologic management of chronic reno-cardiac syndrome

Nael Hawwa1, Martin J Schreiber, W H Wilson Tang

  • 1Medicine Institute, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195, USA.

Current Heart Failure Reports
|November 13, 2012
PubMed

Insights

Chronic kidney disease (CKD) patients face higher cardiovascular risks due to under-treatment and uremic complications. Managing the reno-cardiac syndrome (RCS) involves addressing these interconnected factors for better outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) is a significant risk factor for cardiovascular morbidity and mortality.
  • CKD patients are under-represented in cardiovascular trials and often undertreated for cardiovascular disease.
  • Uremia-related complications in CKD contribute to myocardial dysfunction, termed uremic cardiomyopathy.

Purpose of the Study:

  • To discuss the pathophysiology of the reno-cardiac syndrome (RCS).
  • To present clinical data on the management of RCS.
  • To highlight the need for multi-faceted management strategies for RCS.

Main Methods:

  • Review of pathophysiology linking CKD and cardiovascular disease.
  • Analysis of clinical data concerning RCS management.
  • Discussion of neurohormonal pathway activation in uremic cardiomyopathy.

Main Results:

  • Uremic cardiomyopathy results from over-activated neurohormonal pathways.
  • Effective RCS management requires targeting multiple contributing factors.
  • Clinical data supports a multi-faceted approach to RCS treatment.

Conclusions:

  • Reno-cardiac syndrome (RCS) involves complex interactions between kidney and heart disease.
  • Targeting neurohormonal pathways and uremic complications is crucial for managing RCS.
  • Further research and clinical trials are needed to optimize RCS management in CKD patients.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...